Sentence and cancer type
Showing 221-240 of 577 items.
SentenceCancertype
Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type. PCPG,
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. thyroid,
A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. thyroid,
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. thyroid,
RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. thyroid,
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. thyroid,
Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. neuroblastoma,
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. thyroid,
Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. thyroid,
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. PCPG,
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. thyroid,
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. thyroid,
Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma. thyroid,
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. neuroblastoma,
Oncogenic activation of the ret protooncogene in thyroid cancer. thyroid,
[The direct gene test in familial medullary thyroid gland carcinoma and in MEN syndromes. Detection of mutations in the ret proto-oncogene saves screening studies]. thyroid,
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. PCPG,thyroid,
RET oncogene puzzle in Chernobyl thyroid tumours. thyroid,
Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. thyroid,
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. thyroid,